Merck, BioLineRX to study drug combo to fight pancreatic cancer

JERUSALEM (Reuters) - Israeli biopharmaceutical company BioLineRX Ltd said on Tuesday it would collaborate with U.S. industry heavyweight Merck to test a combination of drugs for the treatment of pancreatic cancer.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro